Dishman Carbogen Amcis Limited (NSE:DCAL)
India · Delayed Price · Currency is INR 186.30
+1.00 (0.54%)
Jul 31, 2026, 3:30 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 29.31 billion as of July 31, 2026. Its market cap has decreased by -26.98% in one year.
Market Cap
29.31B
Enterprise Value
50.00B
Revenue
29.32B
Ranking
n/a
PE Ratio
30.05
Stock Price
186.30
ChartMarket Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 29.31B, a decrease of -48.42%. That is a compound annual growth rate of -7.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 29.31B | -24.50% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 688.86B |
| Anthem Biosciences | 441.77B |
| OneSource Specialty Pharma | 193.56B |
| Concord Biotech | 139.14B |
| Blue Jet Healthcare | 115.92B |
| Supriya Lifescience | 69.21B |
| Zota Health Care | 42.44B |
| Panacea Biotec | 25.96B |